Ladenburg Thalmann Financial Services’s Lisata Therapeutics LSTA Stock Holding History
Bought
Maintained
Sold
Other funds holding LSTA
WB
Ladenburg Thalmann Financial Services's LSTA Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services reduced its Lisata Therapeutics (LSTA) stake by 0.84% in Q4 2019, selling an estimated $72 and leaving 235 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #4528.
Ladenburg Thalmann Financial Services first reported a position in LSTA in Q4 2013 and has held it in 25 quarters since. The position peaked at $107K in Q4 2013. 23 funds tracked by Wall St. Rank hold LSTA as of Q4 2019.
- Ladenburg Thalmann Financial Services held 235 shares of Lisata Therapeutics worth $9K as of Q4 2019.
- Ladenburg Thalmann Financial Services sold 2 Lisata Therapeutics shares in Q4 2019, an estimated $72.
- Lisata Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4528 holding.
- Ladenburg Thalmann Financial Services first reported a position in Lisata Therapeutics in Q4 2013 and has held it in 25 quarters since.
- Ladenburg Thalmann Financial Services's Lisata Therapeutics position peaked at $107K in Q4 2013.
- 23 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.